Primary Faculty Within the Global Disease Epidemiology and Control Program Area

Alain Labrique, PhD '07, MHS '99, MS, is an infectious disease epidemiologist who leverages digital innovations to solve public health problems in resource-limited settings.

Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.

Christine Marie George, PhD, studies how to develop effective water, sanitation, and hygiene interventions to reduce enteric diseases and SARS-CoV-2 in low-income countries.

David Sack, MD ’68, is working to eliminate cholera and other enteric infections as public health problems in Africa and Asia using targeted and effective vaccines.

Joanne Katz, ScD ’93, MS, is an epidemiologist with expertise in maternal, neonatal, and child health and extensive work experience in Nepal and other South Asian countries.

Melissa A. Marx, PhD ‘02, MPH ’98, evaluates maternal, child, and infectious disease programs, and has led response efforts for outbreaks including SARS, Ebola, and COVID-19.

Naor Bar-Zeev PhD, MBiostat, MPH, MBBS, is a pediatric infectious disease physician who studies how to maximize vaccine benefits for low-resource, high-mortality areas.

Smisha Agarwal, PhD, MPH '09, MBA, studies how to improve maternal and newborn health in low-income settings by strengthening health systems and using technological solutions.

Ashley Sheffel, DrPH ’19, MPH, uses research to improve maternal and child health and measurements of quality of care in low-resource settings.

B. Aletta Nonyane, PhD, MSc, applies statistical design and analysis methods to investigate the effect of interventions for improving access to HIV and TB healthcare services.

Rupali Limaye, PhD ’12, MPH, MA, studies how health information can best be communicated to individuals in different contexts and through different channels.

Shannon Seopaul, MPH ’15, is leading public health surveillance of infectious diseases in Maryland to inform public policy at the state and national levels.

Yvonne Tam, MHS ’10, uses modeling methods to assess health interventions' impact in reducing maternal, neonatal, and child mortality in low- and middle- income countries.